Kyverna Therapeutics KYTX
NASDAQ KYTX
$6.22 -0.30 (-4.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kyverna Therapeutics (KYTX) Price to Book (2024 - 2026)

Updated

Kyverna Therapeutics' (KYTX) Price to Book was 3.31 for Q2 2026, up 360.2% from 0.72 a year earlier and up 24.1% from the prior quarter.

Analysis

Kyverna Therapeutics (KYTX) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Price to Book at Kyverna Therapeutics was 1.79, up 195.4% from FY2024.

  • By year, Price to Book came in at 0.61 in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Price to Book in data going back to Q1 2024.
  • Year over year, Price to Book has now increased in each of the last four quarters, with growth averaging 203.0% over the last six quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 2.67 (Q1 2026), 1.79 (Q4 2025) and 1.73 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kyverna Therapeutics 382.97 Mn 382.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.31
Mar 31, 2026 2.67
Dec 31, 2025 1.79
Sep 30, 2025 1.73
Jun 30, 2025 0.72
Mar 31, 2025 0.37
Dec 31, 2024 0.61
Sep 30, 2024 0.70
Jun 30, 2024 0.97
Mar 31, 2024 1.63
API Access

Kyverna Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=KYTX&period=max&api_key=YOUR_API_KEY